SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001883076-24-000007
Filing Date
2024-01-11
Accepted
2024-01-11 12:27:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 141354
2 JOINT FILING AGREEMENT Exhibit.pdf EX-1 97603
  Complete submission text file 0001883076-24-000007.txt   277513
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Subject) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91807 | Film No.: 24528657
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1 HILLCREST CENTER DR, SUITE 232 SPRING VALLEY NY 10977
Business Address
Geller Avi (Filed by) CIK: 0001883076 (see all company filings)

Type: SCHEDULE 13G